LabCorp launches coronavirus neutralizing antibody test

LabCorp (NYSE:LH) has launched a new test designed to assess the capacity of antibodies in plasma to inhibit the SARS-CoV-2 virus. It says the assay can be used in the development of a COVID-19 vaccine and in screening convalescent plasma for prophylactic and therapeutic use.

Read original article here